Evidence map›Paper›PMID 29789391›Full record

ArticleThe EMBO journal2018

MST2 kinase suppresses rDNA transcription in response to DNA damage by phosphorylating nucleolar histone H2B.

Dafni Eleftheria Pefani, Maria Laura Tognoli, Deniz Pirincci Ercan, Vassilis Gorgoulis, Eric O'Neill

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Dafni Eleftheria PefaniCRUK/MRC Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK dafni.pefani@oncology.ox.ac.uk eric.oneill@oncology.ox.ac.uk.ORCID 0000-0002-1956-5111
Maria Laura TognoliCRUK/MRC Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.
Deniz Pirincci ErcanCRUK/MRC Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.
Vassilis GorgoulisLaboratory of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Eric O'NeillCRUK/MRC Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK dafni.pefani@oncology.ox.ac.uk eric.oneill@oncology.ox.ac.uk.ORCID 0000-0002-0060-6278
University of Oxford · GBNational and Kapodistrian University of Athens · GRRadboud University Nijmegen · NLUniversity College Dublin · IE

Funding

Cancer Research UK 19277Cancer Research UK A19277
6 · The paper itself

Abstract

The heavily transcribed rDNA repeats that give rise to the ribosomal RNA are clustered in a unique chromatin structure, the nucleolus. Due to its highly repetitive nature and transcriptional activity, the nucleolus is considered a hotspot of genomic instability. Breaks in rDNA induce a transient transcriptional shut down to conserve energy and promote rDNA repair; however, how nucleolar chromatin is modified and impacts on rDNA repair is unknown. Here, we uncover that phosphorylation of serine 14 on histone H2B marks transcriptionally inactive nucleolar chromatin in response to DNA damage. We identified that the MST2 kinase localises at the nucleoli and targets phosphorylation of H2BS14p in an ATM-dependent manner. We show that establishment of H2BS14p is necessary for damage-induced rDNA transcriptional shut down and maintenance of genomic integrity. Ablation of MST2 kinase, or upstream activators, results in defective establishment of nucleolar H2BS14p, perturbed DNA damage repair, sensitisation to rDNA damage and increased cell lethality. We highlight the impact of chromatin regulation in the rDNA damage response and targeting of the nucleolus as an emerging cancer therapeutic approach.

Indexed as

Ataxia Telangiectasia Mutated ProteinsChromatinDNA Breaks, Double-StrandedDNA DamageDNA RepairDNA, RibosomalHippo KinasesHistonesHumansNucleolus Organizer RegionPhosphorylationProtein Serine-Threonine KinasesSerine-Threonine Kinase 3Transcription, GeneticTumor Suppressor ProteinsAtaxia Telangiectasia Mutated ProteinsATM protein, humanChromatinDNA, RibosomalHippo KinasesHistonesProtein Serine-Threonine KinasesRASSF1 protein, humanSerine-Threonine Kinase 3STK3 protein, humanTumor Suppressor ProteinsATMchromatinDNA damageRASSF1ArDNA transcription

Identifiers

PMID29789391
PMCPMC6068430
OpenAlexW2803877870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.